PMID- 16987003 OWN - NLM STAT- MEDLINE DCOM- 20070104 LR - 20180815 IS - 1523-0864 (Print) IS - 1523-0864 (Linking) VI - 8 IP - 9-10 DP - 2006 Sep-Oct TI - Mechanoregulation of monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. PG - 1461-71 AB - The authors have previously shown that arterial wall strain mediates the development of vessel wall inflammation in experimental hypertension. The current studies explore the mechanoregulation of monocyte chemoattractant protein-1 (MCP-1), a potent pro-inflammatory chemokine, by mitogen-activated protein kinases (MAPK) and oxidative stress. Rat aortic smooth muscle (RASM) cells were subjected to cyclic strain on a uniform biaxial strain device. Strain rapidly activated both ERK1/2(MAPK) and p38(MAPK), with peak activation at 5 min. Strain induced a twofold increase in MCP-1 mRNA, which was attenuated by PD 98059, a specific ERK1/2(MAPK) inhibitor, and SB 203580, a specific p38(MAPK) inhibitor. Cyclic strain also increased production of superoxide anion via an NADPH oxidase-dependent mechanism. To assess the potential role of reactive oxygen species in MAPK activation, cells were stretched in the presence of N-acetylcysteine, which had no effect on p38(MAPK) activation, but significantly inhibited ERK1/2(MAPK) activation and MCP-1 expression. In conclusion, redox-sensitive activation of ERK1/2(MAPK) and redox-insensitive activation of p38(MAPK) regulate straininduced MCP-1 expression in RASM cells. These findings define a role for MAPK signal transduction in establishing a pro-inflammatory state in the arterial wall, and thus implicate a potential molecular link between arterial wall strain and atherosclerosis. FAU - Guest, Thomas M AU - Guest TM AD - Division of Cardiology, Atlanta VAMC and Emory University School of Medicine, Atlanta, Georgia 30322, USA. FAU - Vlastos, George AU - Vlastos G FAU - Alameddine, Fadi M F AU - Alameddine FM FAU - Taylor, W Robert AU - Taylor WR LA - eng GR - HL-09875/HL/NHLBI NIH HHS/United States GR - P01 HL58000/HL/NHLBI NIH HHS/United States GR - R01 HL70531/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - Antioxid Redox Signal JT - Antioxidants & redox signaling JID - 100888899 RN - 0 (Ccl2 protein, rat) RN - 0 (Chemokine CCL2) RN - 0 (Flavonoids) RN - 0 (Imidazoles) RN - 0 (Protein Kinase Inhibitors) RN - 0 (Pyridines) RN - 0 (RNA, Antisense) RN - 11062-77-4 (Superoxides) RN - BBX060AN9V (Hydrogen Peroxide) RN - EC 1.11.1.6 (Catalase) RN - EC 1.6.- (NADH, NADPH Oxidoreductases) RN - EC 1.6.3.- (NADPH Oxidase 1) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) RN - OU13V1EYWQ (SB 203580) RN - SJE1IO5E3I (2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one) RN - WYQ7N0BPYC (Acetylcysteine) SB - IM MH - Acetylcysteine/pharmacology MH - Animals MH - Catalase/genetics/metabolism MH - Cells, Cultured MH - Chemokine CCL2/*genetics MH - Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors/metabolism MH - Flavonoids/pharmacology MH - Gene Expression/drug effects MH - Hydrogen Peroxide/metabolism MH - Imidazoles/pharmacology MH - Mechanotransduction, Cellular/*physiology MH - Muscle, Smooth, Vascular/cytology MH - Myocytes, Smooth Muscle/drug effects/*metabolism MH - NADH, NADPH Oxidoreductases/genetics MH - NADPH Oxidase 1 MH - Oxidation-Reduction MH - Phosphorylation MH - Physical Stimulation MH - Protein Kinase Inhibitors/pharmacology MH - Pyridines/pharmacology MH - RNA, Antisense/genetics MH - Rats MH - Superoxides/metabolism MH - Transfection MH - p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors/metabolism EDAT- 2006/09/22 09:00 MHDA- 2007/01/05 09:00 CRDT- 2006/09/22 09:00 PHST- 2006/09/22 09:00 [pubmed] PHST- 2007/01/05 09:00 [medline] PHST- 2006/09/22 09:00 [entrez] AID - 10.1089/ars.2006.8.1461 [doi] PST - ppublish SO - Antioxid Redox Signal. 2006 Sep-Oct;8(9-10):1461-71. doi: 10.1089/ars.2006.8.1461.